ERVW-1 and HIV infectious disease: Similarly, most of the genetic diversity in HIV (and other rapidly mutating viruses) occurs in the envelope proteins that mediate virus entry, motivating the development of mAb therapies that exclusively target these surface viral proteins for the prevention and treatment of HIV infection (26, 27).